ARRDC3 regulates the targeted therapy sensitivity of clear cell renal cell carcinoma by promoting AXL degradation
Sign Up to like & getrecommendations! Published in 2024 at "Cell Cycle"
DOI: 10.1080/15384101.2024.2308411
Abstract: ABSTRACT AXL plays crucial roles in the tumorigenesis, progression, and drug resistance of neoplasms; however, the mechanisms associated with AXL overexpression in tumors remain largely unknown. In this study, to investigate these molecular mechanisms, wildtype… read more here.
Keywords: renal cell; axl; cell; sensitivity clear ... See more keywords